Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 66,650 clinical trials worldwide
Search
Showing 19051-19100 of 66,650 trials
Active filters:
Status: Recruiting
Clinical Trials (66,650)
NCT06325813
ADHD PreSMA Response Inhibition Therapy
NA
Recruiting
40 participants
Started: Sep 3, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06556433
Family-Based Financial Incentives Intervention for Smoking Cessation
NA
Recruiting
1,312 participants
Started: Sep 3, 2024 · Completed: Jan 31, 2028
1 condition
3 sponsors
1 location
NCT06274801
Open-label Extension Study of Seralutinib in Adult Subjects With PAH (PROSERA-EXT)
PHASE3
Recruiting
300 participants
Started: Sep 3, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
107 locations
NCT05590624
Metabolic Impact of Prospective Controlled Mediterranean Type Diets on Prostate Cancer
NA
Recruiting
30 participants
Started: Sep 3, 2024 · Completed: Jun 30, 2026
1 condition
1 sponsor
1 location
NCT06635798
A Phase III Clinical Trail to Evaluate the Efficacy, Safety, Pharmacokinetics and Immunogenicity Characteristics of GR2001 Injection
PHASE3
Recruiting
582 participants
Started: Sep 3, 2024 · Completed: Mar 4, 2025
1 condition
1 sponsor
20 locations
NCT06445608
PIvotal Trial of the KARDION Cory P4 MechANical Circulatory SupporT SystEm
NA
Recruiting
310 participants
Started: Sep 3, 2024 · Completed: Dec 31, 2025
1 condition
1 sponsor
18 locations
NCT06384963
Respiratory Sinus Arrhythmia Pacing Post-CABG Surgery in Patients With HFrEF
NA
Recruiting
54 participants
Started: Sep 2, 2024 · Completed: Apr 1, 2026
1 condition
2 sponsors
3 locations
NCT06471634
A Study Looking to Improve Sleep and Reduce Sedentary Behaviour in Those Living With Type 2 Diabetes Mellitus
NA
Recruiting
44 participants
Started: Sep 2, 2024 · Completed: Jul 31, 2026
3 conditions
2 sponsors
1 location
NCT06565988
A Post-market-clinical Follow-up Investigation of Safety and Performance by Decoria® Voluma
NA
Recruiting
125 participants
Started: Sep 2, 2024 · Completed: Sep 30, 2025
1 condition
2 sponsors
7 locations
NCT06582576
Mechanisms of Action for the Enterra Medical Gastric Electrical Stimulator
N/A
Recruiting
30 participants
Started: Sep 2, 2024 · Completed: Oct 1, 2025
3 conditions
3 sponsors
1 location
NCT06249126
Primary Subtalar Arthrodesis for Calcaneal Fractures
NA
Recruiting
218 participants
Started: Sep 2, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
16 locations
NCT06356025
Botulinum Toxin Injection in the UES for R-CPD
PHASE4
Recruiting
30 participants
Started: Sep 2, 2024 · Completed: Jul 31, 2027
1 condition
2 sponsors
1 location
NCT06967168
HeEL Pain Pathways Feasibility Study
NA
Recruiting
50 participants
Started: Sep 2, 2024 · Completed: Nov 28, 2025
1 condition
1 sponsor
1 location
NCT06544785
Zanubrutinib With Obinutuzumab in Untreated Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
PHASE2
Recruiting
106 participants
Started: Sep 2, 2024 · Completed: May 31, 2032
2 conditions
1 sponsor
1 location
NCT06565026
CS-206 in Patients With Sickle Cell Disease
EARLY_PHASE1
Recruiting
5 participants
Started: Sep 2, 2024 · Completed: Jun 30, 2027
1 condition
2 sponsors
1 location
NCT06215989
Treatment of ACuTe Coronary Syndromes With Low-dose colchICine
NA
Recruiting
6,574 participants
Started: Sep 2, 2024 · Completed: Jun 30, 2028
5 conditions
1 sponsor
1 location
NCT06283719
Dose Escalation Study of ZG006 in Participants With Advanced Small Cell Lung Cancer or Neuroendocrine Carcinoma, Followed by Dose Expansion Study in Participants With Advanced Small Cell Lung Cancer
PHASE1/PHASE2
Recruiting
105 participants
Started: Sep 2, 2024 · Completed: Apr 30, 2026
2 conditions
1 sponsor
1 location
NCT06292585
Acute EpiDural Hematoma Treated With Middle Meningeal Artery Embolization: a Randomized Trial (AEDH-MT)
NA
Recruiting
194 participants
Started: Sep 2, 2024 · Completed: Dec 31, 2026
2 conditions
2 sponsors
1 location
NCT06579937
Effects of Esketamine on Postoperative Behavioral Changes in Children Undergoing Tonsillectomy and/or Adenoidectomy
PHASE4
Recruiting
172 participants
Started: Sep 2, 2024 · Completed: Oct 30, 2025
1 condition
1 sponsor
1 location
NCT06575179
Dexmedetomidine Reduces Sevoflurane MAC-BAR During Pneumoperitoneum
PHASE4
Recruiting
90 participants
Started: Sep 2, 2024 · Completed: Dec 30, 2024
1 condition
1 sponsor
1 location
NCT05851534
Preoperative Optimisation of Modifiable Risk Factors in Surgery of the Pancreas
NA
Recruiting
2,575 participants
Started: Sep 2, 2024 · Completed: Sep 2, 2028
4 conditions
2 sponsors
13 locations
NCT06612359
Impact of the BOOST GAIT Program on Gait Recovery and Functional Mobility After Stroke
PHASE1
Recruiting
12 participants
Started: Sep 2, 2024 · Completed: Dec 31, 2024
2 conditions
2 sponsors
1 location
NCT06026592
Detection of Plasma DNA of Renal Origin in Kidney Transplant Patients
N/A
Recruiting
30 participants
Started: Sep 2, 2024 · Completed: Jul 9, 2026
2 conditions
1 sponsor
1 location
NCT06756438
Efficacy Evaluation and Cutaneous Acceptibility of a Dermocosmetic Product on Subjects Suffering of Atopic Dermatisis.
NA
Recruiting
88 participants
Started: Sep 2, 2024 · Completed: Sep 1, 2025
2 conditions
1 sponsor
1 location
NCT06576271
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants and Healthy Chinese and Japanese Participants
PHASE1
Recruiting
138 participants
Started: Sep 2, 2024 · Completed: Jun 1, 2027
1 condition
1 sponsor
1 location
NCT06477536
Long-Term Safety and Efficacy of HB0034 in Subjects With Generalized Pustular Psoriasis
PHASE2/PHASE3
Recruiting
33 participants
Started: Sep 2, 2024 · Completed: Jun 30, 2026
1 condition
1 sponsor
3 locations
NCT06142682
Dexamethasone Eluting Cochlear Implant: a Pivotal Study
NA
Recruiting
60 participants
Started: Sep 2, 2024 · Completed: May 30, 2026
1 condition
1 sponsor
7 locations
NCT07114809
Impact of Anodal tDCS and Virtual Reality on Cognitive Dysfunction in Patients With Multiple Sclerosis
NA
Recruiting
80 participants
Started: Sep 2, 2024 · Completed: Jan 31, 2026
2 conditions
2 sponsors
3 locations
NCT07122960
Strengthening Informed Consent for Authentic Participation in Perinatal HIV Research
NA
Recruiting
60 participants
Started: Sep 2, 2024 · Completed: Jul 31, 2026
1 condition
3 sponsors
1 location
NCT06309641
Methemoglobinemia Following Intravenous Iron Treatment
N/A
Recruiting
80 participants
Started: Sep 2, 2024 · Completed: Dec 31, 2025
4 conditions
1 sponsor
1 location
NCT06138990
Pharmacoscopy-guided Clinical Standard-of-care in r/r AML
PHASE2
Recruiting
88 participants
Started: Sep 2, 2024 · Completed: Jun 30, 2026
1 condition
3 sponsors
2 locations
NCT06594250
Study of the Nasal Intracellular Reservoir of Staphylococcus Aureus in Patients With S. Aureus Bacteremia
N/A
Recruiting
405 participants
Started: Sep 2, 2024 · Completed: Nov 30, 2025
1 condition
1 sponsor
1 location
NCT06590103
Effectiveness of Integrating Physically Active Learning Through Co-teaching in Extremadura: ACTIVA-MENTE Project
NA
Recruiting
800 participants
Started: Sep 2, 2024 · Completed: Jun 15, 2025
3 conditions
2 sponsors
1 location
NCT06598488
Beetroot Juice: A Natural Boost for Cardiovascular Health in Postmenopausal Women?
NA
Recruiting
20 participants
Started: Sep 2, 2024 · Completed: Jan 1, 2028
1 condition
1 sponsor
1 location
NCT06614790
Niraparib Maintenance Treatment in Patients With Newly Diagnosed Advanced Platinum- Sensitive, OC. The First Poland RWE Study.
N/A
Recruiting
300 participants
Started: Sep 2, 2024 · Completed: Jan 7, 2026
1 condition
1 sponsor
12 locations
NCT06545812
Immune Response During the Conservative and Minimal Invasive Treatment of Pain Caused by Lumbar Disc Herniation
NA
Recruiting
128 participants
Started: Sep 2, 2024 · Completed: Mar 2, 2026
4 conditions
1 sponsor
1 location
NCT06667414
Frequency of Selected Single Nucleotide Polymorphisms in Huntington Disease Gene Expansion Carriers
N/A
Recruiting
600 participants
Started: Sep 2, 2024 · Completed: Sep 24, 2028
1 condition
1 sponsor
44 locations
NCT06641856
Respiratory Virome Diversity and Baseline Immunity in Healthy Individuals in Shanghai
N/A
Recruiting
300 participants
Started: Sep 2, 2024 · Completed: Dec 31, 2026
1 condition
1 sponsor
1 location
NCT06576375
Efficacy of Dapagliflozin Versus Metformin in Polycystic Ovary Syndrome
PHASE3
Recruiting
70 participants
Started: Sep 2, 2024 · Completed: Jan 31, 2025
1 condition
2 sponsors
1 location
NCT06652087
Rifaximin and Cardiac Function in Patients with Heart Failure with Preserved Ejection Fraction
NA
Recruiting
40 participants
Started: Sep 2, 2024 · Completed: Sep 30, 2027
2 conditions
1 sponsor
1 location
NCT06559501
Integrated Case Management for Burns Care in Pakistan
NA
Recruiting
1,146 participants
Started: Sep 2, 2024 · Completed: Oct 31, 2026
4 conditions
2 sponsors
11 locations
NCT06610305
Ovarian Hormone Withdrawal, Anhedonia, and Reward Sensitivity in Women With Premenstrual Exacerbations of Depression
PHASE4
Recruiting
75 participants
Started: Sep 2, 2024 · Completed: Jul 1, 2026
1 condition
2 sponsors
1 location
NCT06496958
Water Exchange and CO2 Insufflation with Abdominal Compression Device to Reduce Manual Assistance
NA
Recruiting
400 participants
Started: Sep 2, 2024 · Completed: Sep 30, 2026
4 conditions
3 sponsors
2 locations
NCT06359379
Ropidoxuridine as a Radiosensitizer in Newly Diagnosed IDH-Wildtype Glioblastoma With Unmethylated MGMT Promoter
PHASE2
Recruiting
54 participants
Started: Sep 2, 2024 · Completed: Feb 28, 2027
1 condition
1 sponsor
6 locations
NCT06812858
PD-1 Inhibitors Maintenance for cHL Post-autoHCT
PHASE2
Recruiting
83 participants
Started: Sep 2, 2024 · Completed: Sep 30, 2030
1 condition
1 sponsor
3 locations
NCT06581666
Current Awareness, Perspective and Knowledge on Social Egg Freezing
N/A
Recruiting
200 participants
Started: Sep 1, 2024 · Completed: Sep 1, 2030
1 condition
1 sponsor
1 location
NCT07045532
Assessment the Effectiveness of BTVA in COPD and Ablation in Pulmonary Nodules by Pulmonary MRI
N/A
Recruiting
100 participants
Started: Sep 1, 2024 · Completed: Sep 30, 2026
2 conditions
1 sponsor
1 location
NCT07044921
Clinical Study of Irinotecan Liposome (II)-Based Combination Treatment for Irinotecan-resistant Colorectal Cancer.
PHASE2
Recruiting
30 participants
Started: Sep 1, 2024 · Completed: Jul 31, 2027
1 condition
1 sponsor
1 location
NCT06560528
Disitamab Vedotin Combined With Tislelizumab and Capecitabine in the Perioperative Treatment of Locally Advanced Gastric Cancer With HER2 Overexpression
PHASE2
Recruiting
40 participants
Started: Sep 1, 2024 · Completed: Sep 1, 2028
2 conditions
1 sponsor
2 locations
NCT06582641
Evaluation of Peer Group Connection - Middle School
NA
Recruiting
1,400 participants
Started: Sep 1, 2024 · Completed: Sep 14, 2028
1 condition
5 sponsors
1 location
Previous
1
More pages
379
380
381
382
383
384
385
More pages
1333
Next